NRIX
Nurix Therapeutics, Inc.
$24.31
-0.09 (-0.37%)
At close · Jul 8
Market Cap
$2.51B
Shares
103,405,813
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-11 | — | |
| 8-K | 2026-06-08 | 2026-06-06 | |
| Investor Event Transcript | 2026-05-31 | — | |
| 8-K | 2026-05-15 | — | |
| 8-K | 2026-04-08 | — | |
| 10-Q | 2026-04-08 | 2026-02-28 | |
| DEF 14A | 2026-03-27 | 2026-05-15 | |
| 8-K | 2026-03-06 | — | |
| 10-K | 2026-01-28 | 2025-11-30 | |
| 8-K | 2026-01-28 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-12-09 | 2025-12-06 | |
| 8-K | 2025-11-10 | 2025-11-06 | |
| 8-K | 2025-10-22 | — | |
| 8-K | 2025-10-22 | — | |
| 8-K | 2025-10-09 | — | |
| 10-Q | 2025-10-09 | 2025-08-31 | |
| 8-K | 2025-09-03 | — | |
| 8-K | 2025-08-22 | 2025-08-19 | |
| 8-K | 2025-07-09 | — | |
| 10-Q | 2025-07-09 | 2025-05-31 | |
| 8-K | 2025-06-12 | — | |
| 8-K | 2025-05-19 | — | |
| 10-Q | 2025-04-08 | 2025-02-28 | |
| 8-K | 2025-04-08 | — | |
| DEF 14A | 2025-03-28 | 2025-05-19 | |
| 8-K | 2025-03-13 | 2025-03-11 | |
| 10-K | 2025-01-28 | 2024-11-30 | |
| 8-K | 2025-01-28 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-12-10 | 2024-12-09 | |
| 8-K | 2024-10-31 | — | |
| 8-K | 2024-10-16 | 2024-10-15 | |
| 8-K | 2024-10-11 | — | |
| 10-Q | 2024-10-11 | 2024-08-31 | |
| 8-K | 2024-09-05 | — | |
| 10-Q | 2024-07-11 | 2024-05-31 | |
| 8-K | 2024-07-11 | — | |
| 8-K | 2024-06-17 | 2024-06-16 | |
| 8-K | 2024-05-21 | 2024-05-20 | |
| 8-K | 2024-04-12 | 2024-04-11 | |
| 10-Q | 2024-04-10 | 2024-02-29 | |
| 8-K | 2024-04-10 | — | |
| 8-K | 2024-04-09 | — | |
| DEF 14A | 2024-03-27 | 2024-05-20 | |
| 8-K | 2024-03-11 | — | |
| 10-K | 2024-02-15 | 2023-11-30 | |
| 8-K | 2024-02-15 | — | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2023-12-11 | — |
Showing 1–50 of 107 filings